Edition:
India

Sobi Says Completed Tender Offer For All Outstanding Shares Of Dova Pharmaceuticals


Saturday, 9 Nov 2019 

Nov 9 (Reuters) - Swedish Orphan Biovitrum ::SOBI SUCCESSFULLY COMPLETES TENDER OFFER FOR ALL OUTSTANDING SHARES OF DOVA PHARMACEUTICALS.CO'S UNIT DRAGONFLY SUCCESSFULLY COMPLETED ITS TENDER OFFER TO BUY ALL OUTSTANDING SHARES OF DOVA FOR $27.50 PER SHARE.UPON COMPLETION OF MERGER, DOVA WILL BECOME AN INDIRECT WHOLLY OWNED SUBSIDIARY OF SOBI.TENDER OFFER TO BUY DOVA'S ALL SHARES FOR $27.50 PER SHARE, NET TO SELLER THEREOF IN CASH, WITHOUT INTEREST. 

Company Quote

182.45
-10.25 -5.32%
24 Feb 2020